Johnson & Johnson TECVAYLI shows survival benefits in myeloma study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. MU
2. SPY
3. APTX:CN
4. IQMX
5. EROC
6. MSTR
7. TSLA
8. MSFT
9. SEER
10. NVDA

Go back to Johnson & Johnson TECVAYLI shows survival benefits in myeloma study
Johnson & Johnson (NYSE: JNJ) Delayed: 259.33 -3.71 (1.41%)
Previous Close $263.04    52 Week High $126.07 
Open $260.23    52 Week Low $94.28 
Day High $261.38    P/E 53.91 
Day Low $255.93    EPS $4.81 
Volume 6,671,610